APOBEC3G expression and HIV-1 infection in Burkina Faso
Author(s) -
Tégwindé Rebeca Compaore,
Serge Théophile Soubeïga,
Abdoul Karim Ouattara,
Daméhan Tchelougou,
Cyrille Bisseyé,
Didier Romuald Bakouan,
Issaka Pierre Compaore,
Augustine Dembele,
Albert Théophane Yonli,
Dorcas ObiriYeboah,
Florencia Wendkuuni Djigma,
Jacques Simporé
Publication year - 2018
Publication title -
journal of public health in africa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 12
eISSN - 2038-9930
pISSN - 2038-9922
DOI - 10.4081/jphia.2018.907
Subject(s) - apobec3g , virology , biology , cytidine deaminase , samhd1 , human immunodeficiency virus (hiv) , allele , complementary dna , genetics , viral replication , microbiology and biotechnology , virus , reverse transcriptase , gene , polymerase chain reaction
APOBEC3G is a potent inhibitor of HIV-1 replication, and act by deaminating cytidines in uracil on the negative strand of the viral cDNA. In this case-control study, expression in subjects' naïve to HAART infected by HIV-1 and the effect of APOBEC3G polymorphism on its expression were evaluated. The results show that the HIV-1 infected carriers of the G minor alleles of the variant rs8177832 had a higher expression of mRNA than the controls carriers of the G minor allele. polymorphisms could play an important role in the modulation of the HIV-1 dissemination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom